Last reviewed · How we verify

NCT03856320: TOTAL

Teaching Obesity Treatment Options to Adult Learners Trial

Completed NA Results posted Last updated 25 July 2023
What this trial tests

NA trial testing Educational Video in Obesity in 42 participants. Completed in 18 February 2020.

Timeline
13 May 2019
Primary endpoint
18 February 2020
18 February 2020

Quick facts

Lead sponsorVA Office of Research and Development
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment42
Start date13 May 2019
Primary completion18 February 2020
Estimated completion18 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Adults 18 to 75, any sex, with Obesity or Patient Education. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Recruitment Primary · 1 year

The proportion of patients who were contacted by the study team who also consented and provided baseline assessment data.

GroupValue95% CI
All Attempted Recruitment42
Retention Primary · 7-14 days

The proportion of patients who consented and completed the baseline assessment who also completed the post assessment.

GroupValue95% CI
Retention40

Sponsor's own description

Obesity is the second leading cause of death in the U.S. The treatment of obesity and its related health issues, including cardiovascular disease and diabetes, exceeds $150 billion annually. "Morbidly" or "severely" obese patients - defined by a body mass index \[BMI\] of \>35 kg/m2 or greater - are especially high risk for serious complications due to their weight. Within the Veterans Health Administration (VA) system, nearly 600,000 patients are severely obese. These Veterans create significant costs for the VA system, experience poorer quality of life, and have shortened lifespans. Bariatric surgery is the most effective treatment for severe obesity for weight loss, resolving weight-related health issues, and quality of life. Bariatric surgery is supported as a treatment option by many national societies, including those representing primary care and endocrinology. However, less than 1% of Veterans who qualify for bariatric surgery undergo it. Reasons for low utilization are unclear, although the investigators' preliminary research suggests that there are various patient, provider and system level barriers to severe obesity care. The goal of this study is to pilot-test an educational video that aligns patient preferences with treatment options to improve the care that severely obese Veterans receive.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Protocol and short-term results for a feasibility randomized controlled trial of a video intervention for Veterans with obesity: The TOTAL (Teaching Obesity Treatment Options to Adult Learners) pilot study.
    Funk LM, Breuer CR, Venkatesh M, Muraveva A, et al · · 2021 · cited 2× · PMID 34258469 · DOI 10.1016/j.conctc.2021.100816

Verify or expand the search:

Other trials of Educational Video

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03856320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing